Introduction
Stroke has declined to the fifth most common cause of death in the United States after devoting extensive efforts for controlling stroke risk factors and optimizing acute care of stroke patients [1] . However, stroke remains a leading cause of disability among adults in the United States and globally [1] [2] [3] . Of the estimated 800,000 strokes that occur in the US per year, the majority of stroke survivors develop long-term functional deficits [1] . The NINDS sponsored r-tPA trials have reported that the percentage of patients that still had mild to moderate functional deficits (Modified Rankin Scale of 2-5) at 3 and 12 months after a stroke were 44% and 35%, respectively, despite the fact that they received r-tPA in the acute phase [4, 5] . Although these functional deficits may include cognitive, speech, visual, sensory and motor deficits, the most commonly recognized deficit after stroke is motor impairment that have negative impact on subject's mobility and quality of life [5] .
Functional deficits after stroke are also associated with huge financial burden on the patient, family, and society. It is estimated the average lifetime cost of caring for one stroke patient (across all stroke sub-types) was about $103,576 in 1990 which included the cost of acute care, long-term ambulatory care, and nursing home care [6] . The overall financial cost of post-stroke management of patients as well as the demand on rehabilitation therapy has also increased with the increase in numbers of stroke survivors reaching an annual total of $3.4 billion in the US [1] .
Post-stroke motor recovery is a complex, dynamic, and multifactorial process in which an interplay among genetic, pathophysiologic, sociodemographic and therapeutic factors determines the overall recovery trajectory. Therefore, rehabilitation strategies that aim to improve post-stroke recovery outcomes require a thorough understanding of those major determinants. In this paper, we review the major factors influencing post-stroke motor recovery and its implication for neurotherapy after brain injury. We categorized those factors into three groups socio-demographic factors (age, gender, race, socio-economic status and others), clinical factors (the initial injury, co-morbidities, post-stroke depression and rehabilitation therapeutics), and genetic factors (Fig. 1 ).
Socio-demographic factors

Age
Older age is commonly identified as a significant prognostic factor for poorer outcome after ischemic and hemorrhagic stroke where nearly half of older stroke survivors experience mild-tosevere disability [7] [8] [9] [10] [11] , However, the proposed prognostic value of age have been challenged by studies on long-term recovery [12, 13] . Whereas age may be an independent predictor of early outcomes after stroke [14] [15] [16] , the effect of age on long-term outcome measures is less pronounced and may have minimal clinical relevance after adjustment of other factors in regression analysis [12, 17] . Therefore, the influence of age on post-stroke recovery should be distinguished from age-associated factors to assess for the independent prognostic value of age alone. Age-associated confounding factors including co-morbidities and social variables should be taken into consideration before interpretation.
Gender
Females appear less likely to achieve complete functional independence and/or are more likely to be disabled after stroke than male [18] [19] [20] . The underlying causes behind this gender difference are not fully understood, but women are more likely to suffer depressive symptoms [21] and fatigue [22] that can indirectly have negative impact on recovery. A gender-age interaction has been hinted as post-stroke outcomes are actually better in young females as compared to young males [14] . However, this has been challenged by studies reporting lower overall quality of life in female stroke survivors compared to males regardless of age [20, 23] .
Race
Compared to Whites, Blacks have significantly higher stroke incidence [24] , less access to acute therapy [25] , higher stroke mortality [26] , greater initial stroke severity [27] , and higher stroke recurrence [24] . Given the racial variation in co-morbidities, initial stroke severity and rehabilitation service utilization, it is logical to infer the presence of racial variation in post-stroke recovery outcomes. In general, Blacks, along with other minorities, have been shown to have poorer stroke outcomes when compared to Whites [28, 29] . Nonetheless, racial disparities with regard to post-stroke recovery and rehabilitation remains poorly characterized [30, 31] . It is still unclear whether Blacks and Whites follow different poststroke recovery patterns regardless of associated socioeconomic racial disparities. Horner et al. has demonstrated a difference in the trajectory of functional recovery between Blacks and Whites stroke survivors even when there were no major disparities between the two groups in terms of access to or utilization of rehabilitation services [29] . Blacks tend to have greater functional impairment acutely and appear to improve slowly; however, within 3-6 months they reach the approximate activity of daily living (ADL) capacity of their Whites counterparts. Some studies have also reported racial variation in the detection of post stroke depression (PSD) showing that Whites are more likely to be diagnosed with PSD [32] , even after controlling for socio-demographic and clinical characteristics. In addition, compared to Whites, Blacks are found to be less likely to accept or use antidepressants after stroke [33, 34] . Collectively, these studies implicate racial disparities in altering post-stroke motor recovery especially when comparing Blacks and Whites; however, studies in this domain are still scarce, and there is a lack of focused and well-controlled studies comparing the effects of racial factors on stroke recovery.
Socioeconomic status (SES)
Several indicators are used as surrogate measures of SES (e.g., insurance status, education level, household income). SES is also tied with racial factor as Blacks, and other minority groups, have a relatively lower SES. Being uninsured or underinsured may delay or prevent the process of getting access to rehabilitation services and is likely to be associated with poorer recovery outcomes [35] . Higher educational level was significantly associated with a better motor and functional recovery during the inpatient rehabilitation period while income level was only associated with rehabilitation care after discharge from a rehabilitation facility [36] . From a global perspective, socioeconomically deprived individuals in low-, middle-and high-income countries are reported to have higher stroke incidence and poorer short and long-term outcomes after stroke [37] . The most likely underlying reasons for SES-based disparities is the lack of equal access to general healthcare as well as rehabilitation services. It is noteworthy that individuals of lower SES are also more likely to have co-morbidities and cerebrovascular risk factors [37] .
Other factors
While other factors, such as, caregiver support, marital status, disease awareness, mistrust, healthcare system access have been suggested as potential determinants in stroke recovery, additional studies are required to investigate whether these sociodemographic factors independently or collectively contribute to the outcome of stroke survivors [9, 30, 38] .
Clinical factors
Stroke subtype
The two major subtypes of stroke, hemorrhagic and ischemic stroke, result in different patterns of acute and chronic recovery. In general, hemorrhagic stroke patients tend to have greater functional impairment at presentation. However, patients with ICH tend to have a more pronounced and faster recovery than those with ischemic stroke of comparable severity [39] [40] [41] .
The initial injury
Although several reparatory and regenerative processes occur following stroke, the extent of initial injury is a major determinant of chronic recovery as it defines the residual neuronal reservoir that is capable to engage in functional recovery. Therefore, a more severe acute motor impairment is a predictor of more severe chronic deficits, and at the same time, successful thrombolytic therapy may limit initial injury and result in less severe chronic deficits. Duncan et al. [42] reported that initial motor impairment, as measured by the Fugl-Meyer Upper Extremity (FM-UE) Scale, accounted for half of the variance in motor impairment (also measured by FM-UE scale) at 6 months post-stroke (R 2 = 0.53 from the regression analysis). Across the different stroke severity groups, the most dramatic recovery generally occurs in the first 30 days. Additionally, patients with moderate to severe initial impairment continue to experience additional recovery for 90 days and beyond. Baseline measurements of specific muscle and/or joint movement has been proven to have prognostic value. For instance, patients with active finger extension scores more than 3 had a high probability of achieving good performance (as measured by the Motricity Index) at 30, 90, and 180 days [43] . Confirming this data, Nijland et al. showed that patients who are able to perform shoulder abduction and finger extension on day 2 after stroke have 0.98 probability of regaining some dexterity by 6 months compared to a probability of only 0.25 for those without this voluntary motor capability on day 2 [44] .
Assessment of the degree of injury of ipsilesional corticospinal tract (CST), the descending motor pathway that control distal arm and hand muscles, in acute stroke can be used to predict chronic motor deficits. Feng et al. [45] developed an imaging biomarker (weighted CST lesion load, wCST-LL) that indirectly quantifies the extent of involvement of the CST by the stroke lesion. wCST-LL in the acute phase of stroke was found to have a strong predictive value for post-stroke motor outcomes (measured by FM-UE scores) at 3 months, especially in the subgroup of patients with severe motor impairment at baseline. Once the weighted CST lesion load exceeded a threshold of 7.0cc, patients had higher odds to have poor motor outcomes defined as FM-UE score less than 25 at 3 months post-stroke. Interestingly, in subgroup of patient with mild-moderated impairment at baseline, most patients recovered approximately 70% of their maximal recovery potential [46] . Studies performed in heterogeneous cohorts of stroke patients from multiple countries have supported these findings and emphasized the fact that the extent of initial injury is a major prognostic factor of recovery after ischemic stroke [47] [48] [49] . In fact, similar to motor recovery, recovery of language deficits after stroke was also found to have similar proportional recovery [1] . Findings in stroke patients also reflects data from preclinical research showing that although stroke is associated with a significant window of neuroplasticity, the ability for brain re-wiring and plasticity is highly dependent on the amount of residual neuronal substrate that can engage in the remodeling process [50] .
Post-stroke depression (PSD)
PSD is the most frequent neuropsychiatric consequence of stroke affecting as high as one third of stroke survivors [51, 52] . About 12% of males and 16% of females stroke survivors reported that they "always" or "often" felt depressed at 3 months after stroke [21] . The proposed hypothesis on the pathophysiological mechanism behind PSD is the amine hypothesis that suggests a stroke-induced decrease in bioavailability of the biogenic amines (i.e. serotonin, dopamine and norepinephrine) in the brain [53] . Lack of family or social support, stressful events prior to stroke, female gender, major physical disability and prior history of depression have been identified as risk factors for PSD [54] . The interaction between PSD and post-stroke recovery is rather complex, several studies have demonstrated that PSD likely impedes the post-stroke rehabilitation and recovery process and jeopardizes quality of life [51, 55] . Antidepressant use immediately after stroke can enhance motor as well as cognition recovery [56] . In the FLAME study [57] , patients who received fluoxetine 20 mg per day (5-7 days after stroke) gained an average of 34.0 points on FM-UE motor scale at 3 months after stroke compared to 24.3 points in patients taking placebo (p = 0.003) and also had reduced rate of depression. However, the mechanism of the antidepressant may go beyond motivating stroke patients and elevating their mood to be more engaged in rehabilitative therapy. Anti-depressants can also modulate activity in the primary motor cortex through modulating serotonergic signaling, which subsequently induces an extended window of neural plasticity [58, 59] .
Co-morbidities
Patients with diabetes, especially with uncontrolled diabetes, are associated with poorer outcome after stroke [60] . Similarly, severe peri-ventricular white matter disease can adversely affect outcome after stroke [61] . Charlson Index [62] , a measure of num-ber of comorbidities at discharge, is negatively correlated with post-stroke global outcomes (measured by modified Rankin scale) [63] . Careful identification of the contribution of different stroke co-morbidities is key for accurate evaluation of the prognostic value of other factors affecting stroke recovery. In addition to co-morbidities, complications of stroke, such as urinary tract infections, may negatively impact stroke recovery during the acute phase, prolong hospital stay and increase medical costs; however, it is still unknown whether urinary tract infections affect long-term outcomes [64] .
Rehabilitation therapeutics
When discussing the effect of different rehabilitation therapies on chronic motor recovery, it is key to emphasize that in addition to the type of treatment, the timing and the dosage of the treatment also contribute to influencing motor outcome [5] . The effect of the dose of rehabilitation therapy on motor recovery is challenging due to the lack of evidence supporting the hypothesis that a high dose of rehabilitation therapy results in a better motor recovery as systemically reviewed by Cooke et al. [65] These findings are specifically problematic given evidence from independent preclinical labs using rodent models showing that high intensity rehabilitation therapy delivered too early after stroke may impede rather than promote recovery. For instance, high intensity training of the impaired limb can enlarge lesion volume, exacerbate injury, and worsen limb outcome in rodents [66] [67] [68] [69] . Similar findings have been seen in human stroke rehabilitation trials. For instance, Constraint-induced Movement Therapy (CIMT) is a neurobehavioral intervention whose efficacy for upper extremity motor recovery in chronic stroke patients was demonstrated by a multi-center randomized clinical trial [70] . CIMT has two main components: Constraint -restraint of the unaffected upper extremity, and Inducement -forced training of the hemiparetic upper extremity using a shaping paradigm [71] . Benefit from CIMT over traditional therapy was documented in patients who suffered stroke 3-9 months prior to therapy with some residual wrist and finger movement. However, if CIMT is given to patients immediately after stroke, it is found to be only equally as effective as, but not superior to, an equal dose of traditional occupational therapy. Additionally, a higher dose of CIMT failed to provide a similar benefit compared to low dose of CIMT [72] . Lack of dose-response effect in rehabilitation therapy after stroke was also supported by the AVERT-3 trial using a very early mobilization protocol for patients within 24 h of stroke onset. A higher dose (intensity) of mobilization was associated with a reduction in the odds of a favorable outcome at 3 months [73] . Slope or speed of improvement (vs. the degree of improvement) is also important and may have implication for healthcare cost-saving. For example, The Locomotor Experience Applied Post-Stroke (LEAPS) study [74] failed to support the hypothesis that body weight-supported treadmill training (both early and late after stroke) is superior to home-based therapy. However, the study actually showed that the early treatment group appears to reach recovery plateau quicker than the delayed treatment group although the final endpoint is not different between the two groups.
Currently there is no consensus on the optimal neurorehabilitative intervention for enhancing motor recovery after stroke. Several studies to date have investigated a wide variety of single and combinatory rehabilitation strategies to enhance motor recovery after stroke; however, a significant superiority over traditional occupational and physical therapy has not been established yet [5] . Regardless, several innovative neuromodulatory therapies have utilized combinatory paradigms, such as combining brain stimulation with physical rehabilitation, to facilitate the utilization or extension of the window of brain plasticity after stroke. These emerging therapeutics include transcranial direct current stimulation (tDCS), repetitive transcranial magnetic stimulation (rTMS), robotic-assisted devices (RAD), brain-computer interfaces (BCI), and cell-based therapy that may change the recovery trajectory. (summarized in Table 1 ).
Genetic factors
Several studies on genetic variations in stroke and cardiovascular risk have associated multiple single nucleotide polymorphisms (SNPs) with increased risk [75, 76] or severity of ischemic stroke [77] . Yet, investigating genetic variants that may influence chronic recovery and response to rehabilitation therapy is still in infancy. Such genetic polymorphism may account for some of the interindividual variability seen in stroke recovery, and may have implication for individualized rehabilitation programs. A number of gene products, such as Brain Derived Neurotrophic Factor (BDNF) polymorphism [78] [79] [80] [81] [82] [83] , Apolipoprotein E (Apo-E) [84] , Neurotrophic tyrosine kinase receptor [85, 86] , and mitochondrial DNA gene variation may have potential influence on stroke recovery [87] . BDNF is one of the most studied neurotrophic factors in the brain and is implicated in synaptic plasticity [80] , learning and memory [79] . This warrants the hypothesis that variations in BDNF levels post-stroke is implicated in chronic recovery; a hypothesis strongly backed by preclinical studies where exogenous administration of BDNF by either intranasal [81] or intravenous routes [82] enhanced chronic stroke recovery after experimental stroke. In human studies, a functional SNP (rs6252) has been identified in the BDNF gene, in which a G to A substitution at nucleotide 19 results in an amino acid switch from Valine to Methionine at codon 66 (Val66Met). An ethnic variation in this polymorphism exists where 18% of the Finnish [83] , 66% of the Japanese [88] , 52% of the Italian [89] and 32% of the American population [79] has Val66Met polymorphism. This polymorphism has been shown to partially affect activity-dependent BDNF secretion by reducing BDNF secretion by 30% in Met/Met neurons in-vitro [90] and to impair motor skill acquisition in-vivo [78, 79] . In patients with ischemic stroke, the Val66Met allele was associated with poor outcomes and physical disability after stroke, and with slower motor recovery [83, [91] [92] [93] . Analysis of pathophysiological difference between Val and Met patients suggests that both can retain the ability to recovery after stroke; however, the rate and trajectory of recovery appears to be difference [94] . In addition, the presence of Met allele was also found to negatively impact the response to rehabilitative treatment including brain stimulation by rTMS [95] [96] [97] . Work by Fritsch et al. and others has also shown that motor learning is enhanced by anodal tDCS in a BDNF-dependent manner where tDCS can promote BDNF-dependent synaptic plasticity [78] .
Apolipoprotein E (Apo-E), another genetic candidate for influencing post-stroke motor recovery [84] , plays an important role in the growth and regeneration of central nervous system tissues and in modulating neuronal repair, remodeling, and protection. Although not fully confirmed in large trials, polymorphism in Apo-E has been associated with variability in recovery after ischemic stroke [98] [99] [100] .
Other less commonly studied genetic factors that may have potential influence on motor recovery after stroke are a polymorphism of Neurotrophic tyrosine kinase receptor [85, 87] , the enzyme catechol-O-methyl transferase (COMT) [101, 102] . Overall, large collaborative studies are needed to better investigate genetic determinants in stroke recovery, and to provide a personalized approach of rehabilitation therapy.
Conclusion
The increased number of stroke survivors creates a high demand for effective and accessible neuro-rehabilitation therapies. A thor- Multiple sclerosis [112] . Traumatic brain injury [113] .
Epidural Cortical Stimulation
Invasive stimulation of the peri-infarct cortex using epi-dural electrodes [114, 115] . [122] . Multiple Sclerosis [123] . Spinal cord injury [124] .
ough understanding of the pathophysiology and pattern of stroke recovery will boost the existing therapeutics and develop new rehabilitational interventions in the pipeline. Equally important is the understanding of non-pathophysiological and modifiable factors that may negatively or positively impact recovery process. Therefore, significant areas for further research in stroke recovery would be to optimize post-stroke outcome prediction, to identify more sensitive and specific biomarkers for recovery, to individualize recovery therapy depending on the severity and pattern of injury, to investigate efficacy of combined several therapeutic modalities, and to understand and ameliorate socioeconomic hurdles to the recovery process. Due to the similarity in neurophysiological and neuropathological response to stroke and other forms of acquired neural injury [103] , identifying determinants of motor recovery after stroke may provide insight into potential factors influencing recovery after other forms of neuronal injury including traumatic brain injury, multiple sclerosis, and spinal cord injury. Finally, it is important to note that understanding the factors influencing post-stroke recovery can be incorporated into individualized recovery plan for stroke patients. For instance, for patients with BDNF polymorphism, a higher intensity of rehabilitation therapy may overcome the genetic impact on stroke recovery [125] .
